Steven Hill
Directeur Général chez NEWHYDROGEN, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Steven Hill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEWHYDROGEN, INC. | Directeur/Membre du Conseil | 20/03/2023 | - |
| Directeur Général | 15/06/2023 | - | |
| Corporate Officer/Principal | 20/03/2023 | 15/06/2023 |
Historique de carrière de Steven Hill
Anciens postes connus de Steven Hill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Hill Investments LLC | Corporate Officer/Principal | 01/10/2016 | 01/02/2023 |
| RELYPSA INC | Comptroller/Controller/Auditor | 01/12/2015 | 01/10/2021 |
Formation de Steven Hill
| Instituto de Empresa SL | Masters Business Admin |
| Utah Valley University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Espagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEWHYDROGEN, INC. | Producer Manufacturing |
| Entreprise privées | 2 |
|---|---|
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
| Hill Investments LLC |
- Bourse
- Insiders
- Steven Hill
- Expérience
